Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Ovarian Cancer

Jalid Sehouli

雅利德·塞胡利

MD, PhD

🏢Charité – Universitätsmedizin Berlin(柏林夏里特大学医学中心)🌐Germany

Professor and Chair, Department of Gynecology; Director, European Competence Center for Ovarian Cancer妇科系教授及系主任;欧洲卵巢癌能力中心主任

58
h-index
2
Key Papers
3
Awards
2
Key Contributions

👥Biography 个人简介

Jalid Sehouli, MD, PhD is Professor and Chair of Gynecology at Charité–Universitätsmedizin Berlin and Director of the European Competence Center for Ovarian Cancer. He leads major international ovarian cancer clinical trials through GCIG, bridging surgical excellence with systemic therapy advances, and has contributed to platinum rechallenge and bevacizumab combination strategies.

Share:

🧪Research Fields 研究领域

Ovarian Cancer卵巢癌
Cytoreductive Surgery细胞减灭手术
Systemic Therapy全身治疗
GCIG International CollaborationGCIG国际合作
Recurrent Ovarian Cancer复发卵巢癌

🎓Key Contributions 主要贡献

GCIG International Ovarian Cancer Trial Leadership

Led and co-led multiple GCIG-endorsed phase III trials investigating systemic therapies and surgical strategies in recurrent ovarian cancer, shaping international treatment guidelines through multinational evidence.

European Competence Center for Ovarian Cancer

Founded and directs the European Competence Center for Ovarian Cancer at Charité Berlin, establishing standards for high-volume ovarian cancer surgery and integrating molecular profiling into clinical decision-making.

Representative Works 代表性著作

[1]

Second surgery versus chemotherapy as treatment of platinum-sensitive recurrent ovarian cancer (DESKTOP III/ENGOT-ov20)

The Lancet Oncology (2021)

Key contributor to DESKTOP III demonstrating that secondary cytoreduction followed by chemotherapy improved progression-free survival in AGO-score positive, platinum-sensitive recurrent ovarian cancer.

[2]

Trabectedin plus pegylated liposomal doxorubicin versus pegylated liposomal doxorubicin alone in patients with platinum-sensitive recurrent ovarian cancer (OVA-301)

Journal of Clinical Oncology (2010)

Phase III trial establishing trabectedin-PLD combination as an effective option for platinum-sensitive recurrent ovarian cancer, particularly in partially platinum-sensitive patients.

🏆Awards & Recognition 奖项与荣誉

🏆German Cancer Society Fritz-Linder Award for Surgical Oncology
🏆European Society of Gynaecological Oncology Distinguished Service Award
🏆Gynecologic Cancer InterGroup (GCIG) Outstanding Contribution Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 雅利德·塞胡利 的研究动态

Follow Jalid Sehouli's research updates

留下邮箱,当我们发布与 Jalid Sehouli(Charité – Universitätsmedizin Berlin)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment